Integrin alpha(v)beta(3)-mediated activation of apoptosis
The alpha(v)beta(3) integrin mediates endothelial cell binding to the extracellular matrix and transduces an intracellular signal promoting survival of endothelial cells and various tumor cells. While the alpha(v)beta(3) integrin-mediated survival signal has been shown to be adhesion dependent, a th...
Gespeichert in:
| Veröffentlicht in: | Experimental cell research 1999-08, Vol.251 (1), p.33-45 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 45 |
|---|---|
| container_issue | 1 |
| container_start_page | 33 |
| container_title | Experimental cell research |
| container_volume | 251 |
| creator | Brassard, D L Maxwell, E Malkowski, M Nagabhushan, T L Kumar, C C Armstrong, L |
| description | The alpha(v)beta(3) integrin mediates endothelial cell binding to the extracellular matrix and transduces an intracellular signal promoting survival of endothelial cells and various tumor cells. While the alpha(v)beta(3) integrin-mediated survival signal has been shown to be adhesion dependent, a thorough analysis has not been performed comparing the biochemical effects of antagonist binding to alpha(v)beta(3) integrin with the effects induced by the growth of cells in suspension. In this study we demonstrate that expression of alpha(v)beta(3) integrin in human embryonic kidney 293 cells transfers the alpha(v)beta(3) integrin survival pathway to an epithelial cell line. Furthermore, we show that alpha(v)beta(3) integrin-expressing cells respond differently to alpha(v)beta(3) integrin-specific antagonist treatment and growth in suspension conditions. Treatment with the alpha(v)beta(3) antagonist echistatin resulted in an apoptotic response occurring prior to cell detachment and was not observed in either suspended cells or antagonist-treated suspended cells. These data suggest that the death induced by antagonist binding to alpha(v)beta(3) integrin results in an apoptotic signal with different kinetics than the apoptotic signal induced by matrix detachment (anoikis). Since aberrant alpha(v)beta(3) integrin expression in tumor models is thought to play a role in tumor cell survival, these data have implications for the use of alpha(v)beta(3) antagonists as anti-tumor agents. |
| doi_str_mv | 10.1006/excr.1999.4559 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69942906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69942906</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-f880687eb13b016b0f143249183a96914feb3908d1150d1673e043847ed205e13</originalsourceid><addsrcrecordid>eNo1jztPwzAURj2AaCmsjCgTaoeEe2PH8R1RxaNSJRaYIye5AaO8iN0K_j1FlOlbjj6dI8QVQoIA-pa_qilBIkpUltGJmAOgipVJ85k49_4DAIxBfSZmCEqaTNNc0KYP_Da5PrLt-G6X-1XJwS7lKu64djZwHdkquL0NbuijoYnsOIxh8M5fiNPGtp4vj7sQrw_3L-unePv8uFnfbeMRJYW4MQa0yblEWQLqEhpUMlWERlrShKrhUhKYGjGDGnUu-VdO5VynkDHKhbj5-x2n4XPHPhSd8xW3re152PlCE6mUQB_A6yO4Kw_yxTi5zk7fxX-s_AHixFJZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69942906</pqid></control><display><type>article</type><title>Integrin alpha(v)beta(3)-mediated activation of apoptosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Brassard, D L ; Maxwell, E ; Malkowski, M ; Nagabhushan, T L ; Kumar, C C ; Armstrong, L</creator><creatorcontrib>Brassard, D L ; Maxwell, E ; Malkowski, M ; Nagabhushan, T L ; Kumar, C C ; Armstrong, L</creatorcontrib><description>The alpha(v)beta(3) integrin mediates endothelial cell binding to the extracellular matrix and transduces an intracellular signal promoting survival of endothelial cells and various tumor cells. While the alpha(v)beta(3) integrin-mediated survival signal has been shown to be adhesion dependent, a thorough analysis has not been performed comparing the biochemical effects of antagonist binding to alpha(v)beta(3) integrin with the effects induced by the growth of cells in suspension. In this study we demonstrate that expression of alpha(v)beta(3) integrin in human embryonic kidney 293 cells transfers the alpha(v)beta(3) integrin survival pathway to an epithelial cell line. Furthermore, we show that alpha(v)beta(3) integrin-expressing cells respond differently to alpha(v)beta(3) integrin-specific antagonist treatment and growth in suspension conditions. Treatment with the alpha(v)beta(3) antagonist echistatin resulted in an apoptotic response occurring prior to cell detachment and was not observed in either suspended cells or antagonist-treated suspended cells. These data suggest that the death induced by antagonist binding to alpha(v)beta(3) integrin results in an apoptotic signal with different kinetics than the apoptotic signal induced by matrix detachment (anoikis). Since aberrant alpha(v)beta(3) integrin expression in tumor models is thought to play a role in tumor cell survival, these data have implications for the use of alpha(v)beta(3) antagonists as anti-tumor agents.</description><identifier>ISSN: 0014-4827</identifier><identifier>DOI: 10.1006/excr.1999.4559</identifier><identifier>PMID: 10438569</identifier><language>eng</language><publisher>United States</publisher><subject>Annexin A5 - metabolism ; Apoptosis - drug effects ; Caspase 3 ; Caspases - metabolism ; Cell Adhesion - drug effects ; Cell Cycle - drug effects ; Cell Line ; Cell Survival - drug effects ; Coumarins - metabolism ; Culture Media, Serum-Free ; Extracellular Matrix Proteins - metabolism ; Humans ; Molecular Weight ; Oligopeptides - metabolism ; Peptides - pharmacology ; Poly(ADP-ribose) Polymerases - metabolism ; Receptors, Vitronectin - antagonists & inhibitors ; Receptors, Vitronectin - genetics ; Receptors, Vitronectin - metabolism ; Signal Transduction - drug effects ; Time Factors ; Transfection</subject><ispartof>Experimental cell research, 1999-08, Vol.251 (1), p.33-45</ispartof><rights>Copyright 1999 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10438569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brassard, D L</creatorcontrib><creatorcontrib>Maxwell, E</creatorcontrib><creatorcontrib>Malkowski, M</creatorcontrib><creatorcontrib>Nagabhushan, T L</creatorcontrib><creatorcontrib>Kumar, C C</creatorcontrib><creatorcontrib>Armstrong, L</creatorcontrib><title>Integrin alpha(v)beta(3)-mediated activation of apoptosis</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>The alpha(v)beta(3) integrin mediates endothelial cell binding to the extracellular matrix and transduces an intracellular signal promoting survival of endothelial cells and various tumor cells. While the alpha(v)beta(3) integrin-mediated survival signal has been shown to be adhesion dependent, a thorough analysis has not been performed comparing the biochemical effects of antagonist binding to alpha(v)beta(3) integrin with the effects induced by the growth of cells in suspension. In this study we demonstrate that expression of alpha(v)beta(3) integrin in human embryonic kidney 293 cells transfers the alpha(v)beta(3) integrin survival pathway to an epithelial cell line. Furthermore, we show that alpha(v)beta(3) integrin-expressing cells respond differently to alpha(v)beta(3) integrin-specific antagonist treatment and growth in suspension conditions. Treatment with the alpha(v)beta(3) antagonist echistatin resulted in an apoptotic response occurring prior to cell detachment and was not observed in either suspended cells or antagonist-treated suspended cells. These data suggest that the death induced by antagonist binding to alpha(v)beta(3) integrin results in an apoptotic signal with different kinetics than the apoptotic signal induced by matrix detachment (anoikis). Since aberrant alpha(v)beta(3) integrin expression in tumor models is thought to play a role in tumor cell survival, these data have implications for the use of alpha(v)beta(3) antagonists as anti-tumor agents.</description><subject>Annexin A5 - metabolism</subject><subject>Apoptosis - drug effects</subject><subject>Caspase 3</subject><subject>Caspases - metabolism</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Coumarins - metabolism</subject><subject>Culture Media, Serum-Free</subject><subject>Extracellular Matrix Proteins - metabolism</subject><subject>Humans</subject><subject>Molecular Weight</subject><subject>Oligopeptides - metabolism</subject><subject>Peptides - pharmacology</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Receptors, Vitronectin - antagonists & inhibitors</subject><subject>Receptors, Vitronectin - genetics</subject><subject>Receptors, Vitronectin - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>0014-4827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jztPwzAURj2AaCmsjCgTaoeEe2PH8R1RxaNSJRaYIye5AaO8iN0K_j1FlOlbjj6dI8QVQoIA-pa_qilBIkpUltGJmAOgipVJ85k49_4DAIxBfSZmCEqaTNNc0KYP_Da5PrLt-G6X-1XJwS7lKu64djZwHdkquL0NbuijoYnsOIxh8M5fiNPGtp4vj7sQrw_3L-unePv8uFnfbeMRJYW4MQa0yblEWQLqEhpUMlWERlrShKrhUhKYGjGDGnUu-VdO5VynkDHKhbj5-x2n4XPHPhSd8xW3re152PlCE6mUQB_A6yO4Kw_yxTi5zk7fxX-s_AHixFJZ</recordid><startdate>19990825</startdate><enddate>19990825</enddate><creator>Brassard, D L</creator><creator>Maxwell, E</creator><creator>Malkowski, M</creator><creator>Nagabhushan, T L</creator><creator>Kumar, C C</creator><creator>Armstrong, L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19990825</creationdate><title>Integrin alpha(v)beta(3)-mediated activation of apoptosis</title><author>Brassard, D L ; Maxwell, E ; Malkowski, M ; Nagabhushan, T L ; Kumar, C C ; Armstrong, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-f880687eb13b016b0f143249183a96914feb3908d1150d1673e043847ed205e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Annexin A5 - metabolism</topic><topic>Apoptosis - drug effects</topic><topic>Caspase 3</topic><topic>Caspases - metabolism</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Coumarins - metabolism</topic><topic>Culture Media, Serum-Free</topic><topic>Extracellular Matrix Proteins - metabolism</topic><topic>Humans</topic><topic>Molecular Weight</topic><topic>Oligopeptides - metabolism</topic><topic>Peptides - pharmacology</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Receptors, Vitronectin - antagonists & inhibitors</topic><topic>Receptors, Vitronectin - genetics</topic><topic>Receptors, Vitronectin - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brassard, D L</creatorcontrib><creatorcontrib>Maxwell, E</creatorcontrib><creatorcontrib>Malkowski, M</creatorcontrib><creatorcontrib>Nagabhushan, T L</creatorcontrib><creatorcontrib>Kumar, C C</creatorcontrib><creatorcontrib>Armstrong, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brassard, D L</au><au>Maxwell, E</au><au>Malkowski, M</au><au>Nagabhushan, T L</au><au>Kumar, C C</au><au>Armstrong, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrin alpha(v)beta(3)-mediated activation of apoptosis</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>1999-08-25</date><risdate>1999</risdate><volume>251</volume><issue>1</issue><spage>33</spage><epage>45</epage><pages>33-45</pages><issn>0014-4827</issn><abstract>The alpha(v)beta(3) integrin mediates endothelial cell binding to the extracellular matrix and transduces an intracellular signal promoting survival of endothelial cells and various tumor cells. While the alpha(v)beta(3) integrin-mediated survival signal has been shown to be adhesion dependent, a thorough analysis has not been performed comparing the biochemical effects of antagonist binding to alpha(v)beta(3) integrin with the effects induced by the growth of cells in suspension. In this study we demonstrate that expression of alpha(v)beta(3) integrin in human embryonic kidney 293 cells transfers the alpha(v)beta(3) integrin survival pathway to an epithelial cell line. Furthermore, we show that alpha(v)beta(3) integrin-expressing cells respond differently to alpha(v)beta(3) integrin-specific antagonist treatment and growth in suspension conditions. Treatment with the alpha(v)beta(3) antagonist echistatin resulted in an apoptotic response occurring prior to cell detachment and was not observed in either suspended cells or antagonist-treated suspended cells. These data suggest that the death induced by antagonist binding to alpha(v)beta(3) integrin results in an apoptotic signal with different kinetics than the apoptotic signal induced by matrix detachment (anoikis). Since aberrant alpha(v)beta(3) integrin expression in tumor models is thought to play a role in tumor cell survival, these data have implications for the use of alpha(v)beta(3) antagonists as anti-tumor agents.</abstract><cop>United States</cop><pmid>10438569</pmid><doi>10.1006/excr.1999.4559</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-4827 |
| ispartof | Experimental cell research, 1999-08, Vol.251 (1), p.33-45 |
| issn | 0014-4827 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69942906 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Annexin A5 - metabolism Apoptosis - drug effects Caspase 3 Caspases - metabolism Cell Adhesion - drug effects Cell Cycle - drug effects Cell Line Cell Survival - drug effects Coumarins - metabolism Culture Media, Serum-Free Extracellular Matrix Proteins - metabolism Humans Molecular Weight Oligopeptides - metabolism Peptides - pharmacology Poly(ADP-ribose) Polymerases - metabolism Receptors, Vitronectin - antagonists & inhibitors Receptors, Vitronectin - genetics Receptors, Vitronectin - metabolism Signal Transduction - drug effects Time Factors Transfection |
| title | Integrin alpha(v)beta(3)-mediated activation of apoptosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A55%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrin%20alpha(v)beta(3)-mediated%20activation%20of%20apoptosis&rft.jtitle=Experimental%20cell%20research&rft.au=Brassard,%20D%20L&rft.date=1999-08-25&rft.volume=251&rft.issue=1&rft.spage=33&rft.epage=45&rft.pages=33-45&rft.issn=0014-4827&rft_id=info:doi/10.1006/excr.1999.4559&rft_dat=%3Cproquest_pubme%3E69942906%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69942906&rft_id=info:pmid/10438569&rfr_iscdi=true |